Related Experiment Video

Updated: May 20, 2026

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

A shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibromatosis-1

Irma B Stowe1, Ellen L Mercado, Timothy R Stowe

  • 1Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94158, USA.

Genes & Development
|July 4, 2012
PubMed

Insights

SPRED1 protein loss causes Legius syndrome by disrupting Ras/MAPK signaling. Neurofibromin (NF1) interacts with Spred1, enabling its inhibitory function and regulating pathway activity.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Genetics

Background:

  • The Ras/mitogen-activated protein kinase (MAPK) pathway is crucial for cell growth and differentiation.
  • Loss-of-function mutations in SPRED1 cause Legius syndrome, a disorder phenotypically similar to Neurofibromatosis-1 (NF1).
  • The precise molecular mechanism by which Spred1 regulates Ras/MAPK signaling remains unclear.

Purpose of the Study:

  • To elucidate the molecular mechanism of Spred1's negative regulation of the Ras/MAPK pathway.
  • To investigate the interaction between Spred1 and neurofibromin (NF1).
  • To understand the link between NF1 and Legius syndrome pathophysiology.

Main Methods:

  • Co-immunoprecipitation assays to detect protein-protein interactions.
  • Western blotting to analyze protein levels and activation states.
  • Fluorescence microscopy to assess protein localization within cells.

Main Results:

  • Neurofibromin (NF1) directly interacts with Spred1.
  • Spred1 binding is essential for Spred1's inhibitory effect on Ras/MAPK signaling.
  • Spred1 induces the plasma membrane localization of NF1.
  • NF1 localization to the plasma membrane leads to decreased Ras-GTP levels, indicating pathway inhibition.

Conclusions:

  • Spred1 acts as a scaffold, recruiting NF1 to the plasma membrane to inhibit Ras/MAPK signaling.
  • This interaction reveals a novel regulatory mechanism for NF1.
  • The findings provide a molecular basis for the overlapping features of Legius syndrome and NF1.

More Related Videos

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas03:53

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas

Published on: October 10, 2025

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...